Cargando…
Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer
Background: Urinary bladder cancer (UBC) is one of the most common causes of morbidity and mortality worldwide characterized by a high risk of invasion and metastasis; however, the molecular classification biomarkers and underlying molecular mechanisms for UBC patient stratification on clinical outc...
Autores principales: | Dalangood, Sumiya, Zhu, Zhen, Ma, Zhihui, Li, Jiaxuan, Zeng, Qinghe, Yan, Yilin, Shen, Bing, Yan, Jun, Huang, Ruimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481430/ https://www.ncbi.nlm.nih.gov/pubmed/32929335 http://dx.doi.org/10.7150/thno.48711 |
Ejemplares similares
-
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021) -
Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion
por: Li, Jiaxuan, et al.
Publicado: (2022) -
Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014) -
ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
por: Videira, Paula A, et al.
Publicado: (2009) -
Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer
por: Ouyang, Song, et al.
Publicado: (2020)